Example: Heart Attack

Search clinical trials for: Lenalidomide

Total 926 results

NCT03701711

Recruiting

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

Conditions: Demyelinating Sensorimotor Neuropathy
NCT02371577

Withdrawn

Evaluation of the Immune Restoration Potential Of Lenalidomide

Conditions: Chronic Lymphocytic Leukemia (CLL)
NCT02370888

Terminated

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

Conditions: Leukemia, Myeloid; Myelodysplastic Syndromes
NCT02018523

Terminated

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Conditions: Carcinoma, Non-Small-Cell Lung
NCT01724177

Completed

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

Conditions: Adult T-Cell Leukemia-Lymphoma
NCT04544059

Not yet recruiting

Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma

Conditions: Diffuse Large B Cell Lymphoma
NCT02279654

Active, not recruiting

Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)

Conditions: Myelodysplastic Syndrome
NCT02302469

Completed

Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia

Conditions: Waldenstrom Macroglobulinemia
NCT04432402

Recruiting

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Conditions: Diffuse Large B Cell Lymphoma
NCT01703364

Completed

Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL

Conditions: CLL; Chronic Lymphocytic Leukemia
NCT02155634

Withdrawn

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Conditions: Multiple Myeloma; Neoplasms; Plasma Cells; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Therapeutic Uses
NCT02354313

Unknown status

Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients

Conditions: MANTLE CELL LYMPHOMA
NCT00847639

Completed

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Conditions: Multiple Myeloma
NCT01575860

Active, not recruiting

Maintenance Lenalidomide in Lymphoma

Conditions: Lymphoma
NCT01816620

Completed

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Conditions: POEMS Syndrome
NCT00799513

Unknown status

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Conditions: Diffuse Large B-cell Lymphoma
NCT02322320

Completed

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Conditions: Multiple Myeloma
NCT01380106

Unknown status

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

Conditions: Multiple Myeloma
NCT02523040

Active, not recruiting

A Study of Lenalidomide for Adult Histiocyte Disorders

Conditions: Langerhans Cell Histiocytosis (LCH); Histiocytoses Erdheim-chester Disease; Histiocytic Sarcoma (HS)
NCT00874978

Completed

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

Conditions: Myelodysplastic Syndromes
NCT03647124

Recruiting

Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden

Conditions: Lymphoma, Mantle-Cell
NCT00901615

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

Conditions: Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma
NCT01057121

Completed

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Conditions: AIDS-Related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
NCT01553786

Completed

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

Conditions: T-cell Lymphoma
NCT00699842

Terminated

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Conditions: Myelodysplastic Syndrome; MDS; Low to Intermediate-1 MDS; Non-deletion 5q